258 related articles for article (PubMed ID: 9781363)
1. Enhanced anti-Candida activity of neutrophils and azole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Okutomi T; Abe S; Hayasawa H; Tomita M; Yamaguchi H
Adv Exp Med Biol; 1998; 443():229-37. PubMed ID: 9781363
[TBL] [Abstract][Full Text] [Related]
2. Cooperative anti-Candida effects of lactoferrin or its peptides in combination with azole antifungal agents.
Wakabayashi H; Abe S; Okutomi T; Tansho S; Kawase K; Yamaguchi H
Microbiol Immunol; 1996; 40(11):821-5. PubMed ID: 8985937
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hyphal growth of azole-resistant strains of Candida albicans by triazole antifungal agents in the presence of lactoferrin-related compounds.
Wakabayashi H; Abe S; Teraguchi S; Hayasawa H; Yamaguchi H
Antimicrob Agents Chemother; 1998 Jul; 42(7):1587-91. PubMed ID: 9660988
[TBL] [Abstract][Full Text] [Related]
4. A novel bovine lactoferrin peptide, FKCRRWQWRM, suppresses Candida cell growth and activates neutrophils.
Ueta E; Tanida T; Osaki T
J Pept Res; 2001 Mar; 57(3):240-9. PubMed ID: 11298926
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antifungal effect of lactoferrin with azole antifungals against Candida albicans and a proposal for a new treatment method for invasive candidiasis.
Kobayashi T; Kakeya H; Miyazaki T; Izumikawa K; Yanagihara K; Ohno H; Yamamoto Y; Tashiro T; Kohno S
Jpn J Infect Dis; 2011; 64(4):292-6. PubMed ID: 21788703
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.
Yoo YC; Watanabe S; Watanabe R; Hata K; Shimazaki K; Azuma I
Jpn J Cancer Res; 1997 Feb; 88(2):184-90. PubMed ID: 9119747
[TBL] [Abstract][Full Text] [Related]
7. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
[TBL] [Abstract][Full Text] [Related]
8. Augmented inhibition of growth of Candida albicans by neutrophils in the presence of lactoferrin.
Okutomi T; Abe S; Tansho S; Wakabayashi H; Kawase K; Yamaguchi H
FEMS Immunol Med Microbiol; 1997 Jun; 18(2):105-12. PubMed ID: 9223614
[TBL] [Abstract][Full Text] [Related]
9. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anti-candida activities of lactoferrin and the lactoperoxidase system.
Nakano M; Suzuki M; Wakabayashi H; Hayama K; Yamauchi K; Abe F; Abe S
Drug Discov Ther; 2019; 13(1):28-33. PubMed ID: 30880319
[TBL] [Abstract][Full Text] [Related]
11. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
Odds FC; Webster CE
J Antimicrob Chemother; 1988 Oct; 22(4):473-81. PubMed ID: 2849601
[TBL] [Abstract][Full Text] [Related]
12. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
[TBL] [Abstract][Full Text] [Related]
13. Lactoferricin, a new antimicrobial peptide.
Jones EM; Smart A; Bloomberg G; Burgess L; Millar MR
J Appl Bacteriol; 1994 Aug; 77(2):208-14. PubMed ID: 7961192
[TBL] [Abstract][Full Text] [Related]
14. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albican strains.
Maesaki S; Marichal P; Hossain MA; Sanglard D; Vanden Bossche H; Kohno S
J Antimicrob Chemother; 1998 Dec; 42(6):747-53. PubMed ID: 10052898
[TBL] [Abstract][Full Text] [Related]
15. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin Is Broadly Active against Yeasts and Highly Synergistic with Amphotericin B.
Fernandes KE; Weeks K; Carter DA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094132
[TBL] [Abstract][Full Text] [Related]
17. Enhanced antifungal activity of bovine lactoferrin-producing probiotic Lactobacillus casei in the murine model of vulvovaginal candidiasis.
Liao H; Liu S; Wang H; Su H; Liu Z
BMC Microbiol; 2019 Jan; 19(1):7. PubMed ID: 30621597
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal sensitivity of fluconazole, clotrimazole and nystatin against vaginal candidiasis in females of childbearing age.
Khan F; Baqai R
J Ayub Med Coll Abbottabad; 2010; 22(4):197-200. PubMed ID: 22455297
[TBL] [Abstract][Full Text] [Related]
20. Impact of Brief Exposure to Drugs with Antifungal Properties on the Susceptibility of Oral Candida dubliniensis Isolates to Lysozyme and Lactoferrin.
Ellepola ANB; Dassanayake RS; Khan Z
Med Princ Pract; 2018; 27(6):523-530. PubMed ID: 30173211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
